Clinical Trials on Metabolic Response to Dietary Modification in Russian Federation
Total 7 results
-
Northern State Medical UniversityCompletedHypocapnia | Response to HyperoxiaRussian Federation
-
Atlas BiomedCompletedStudy of the Genome, Gut Metagenome and Lifestyle of Patients With Incident Type 2 Diabetes MellitusDiabetes Mellitus, Type 2 | Genetic Predisposition | MetagenomeRussian Federation
-
Atlas BiomedTerminatedParkinson Disease | Genetic PredispositionRussian Federation
-
Human Stem Cell Institute, RussiaRyazan State Medical University; Vidnoe District HospitalCompletedUlcers Related to Diabetic Foot SyndromeRussian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare ProfessionalsSpain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
-
Novartis PharmaceuticalsCompletedChronic Iron Overload Due to Transfusion-dependant AnemiasItaly, Austria, Thailand, Spain, Germany, Mexico, Malaysia, Greece, United Kingdom, France, Saudi Arabia, United Arab Emirates, Lebanon, Russian Federation, United States, Argentina
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain